Arrowhead Research | ARWR - Borç Faiz Gideri





Borç Faiz Gideri Değişiklik Tarih
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Incyte USD 569K 13K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Ligand Pharmaceuticals USD 910K 243K 2025-09
Merck USD 412M 85M 2025-12
Moderna USD 12.14B 12.13B 2025-09
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 304M 23M 2025-12
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
TG Therapeutics USD 6.53M 187K 2025-12
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Xencor USD 7.35M 311K 2025-12